Correspondence 0001493152-24-035470 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)

Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 9, 2024 · CIK: 0001922335 · Accession: 0001493152-24-035470

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-281583

Date

September 9, 2024

Author

Form

CORRESP

Company

Syra Health Corp (SYRA) (CIK 0001922335)

Letter

SYRA HEALTH CORP.

1119 Keystone Way N. #201

Carmel, IN 46032

September 9, 2024

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Rucha Pandit

Re: Syra Health Corp.

Registration Statement on Form S-1

Filed August 15, 2024

File No. 333-281583

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Syra Health Corp. (the “Company”) respectfully requests that the effective date of the registration statement referred to above (the “Registration Statement”) be accelerated so that it becomes effective at 4:30 p.m., Eastern Time, on September 11, 2024, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Sincerely,
SYRA HEALTH CORP.

Show Raw Text

CORRESP
1
filename1.htm

SYRA HEALTH CORP.

1119 Keystone Way N. #201

Carmel, IN 46032

September 9, 2024

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Rucha Pandit

 Re: Syra Health Corp.

    Registration Statement on Form S-1

    Filed August 15, 2024

    File No. 333-281583

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and
Regulations under the Securities Act of 1933, as amended, Syra Health Corp. (the “Company”) respectfully requests that the
effective date of the registration statement referred to above (the “Registration Statement”) be accelerated so that it becomes
effective at 4:30 p.m., Eastern Time, on September 11, 2024, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter
& Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared
effective pursuant to this acceleration request.

    Sincerely,

    SYRA HEALTH CORP.

    By:
    /s/
    Deepika Vuppalanchi

    Name:
    Deepika
Vuppalanchi

    Title:
    Chief Executive Officer

SecProbe.io